Evidence map›Paper›PMID 37258128›Full record

ArticleThe Journal of veterinary medical science2023

Peste des Petits Ruminants (PPR) vaccine R&D investment: financial assessment of vaccine development and administration in India.

Gurrappa Naidu Govindaraj, Naveenkumar Gs, Vinayagamurthy Balamurugan, Bibek Rajan Shome, Parimal Roy

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of veterinary medical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gurrappa Naidu GovindarajICAR- National Institute of Veterinary Epidemiology and Disease Informatics (NIVEDI), Karnataka, India.
Naveenkumar GsICAR- National Institute of Veterinary Epidemiology and Disease Informatics (NIVEDI), Karnataka, India.
Vinayagamurthy BalamuruganICAR- National Institute of Veterinary Epidemiology and Disease Informatics (NIVEDI), Karnataka, India.
Bibek Rajan ShomeICAR- National Institute of Veterinary Epidemiology and Disease Informatics (NIVEDI), Karnataka, India.
Parimal RoyICAR- National Institute of Veterinary Epidemiology and Disease Informatics (NIVEDI), Karnataka, India.
National Institute Of Veterinary Epidemiology And Disease Informatics · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study assessed the financial viability of Peste des Petits Ruminants (PPR) vaccine Research & Development (R&D) investment in India and the Gross Technology Revenue (GTR) accrual to the different stakeholders. The Net Present Value (NPV), Internal Rate of Return (IRR) and Benefit Cost Ratio (BCR) of PPR vaccine development and administration were USD 16,326.6 million (INR 130,612 crore), USD 184,54.2 million (INR 147,633 crore) and USD 21,645.6 million (INR 173,164 crore); 162.2%, 167.6% and 169.7% and 43.3:1, 48.8:1 and 57.1:1, respectively under low, medium and high disease incidence scenarios. The estimated cumulative GTR accrued during 2001-02 to 2017-18 by the innovating public research institutions (Indian Council of Agricultural Research-Indian Veterinary Research Institute (ICAR-IVRI) and Tamil Nadu Veterinary and Animal Sciences University (TANUVAS)), private vaccine producers, public sector biologicals and government revenues in terms of taxes was USD 0.696 million (INR 5.568 crore) for ICAR-IVRI and USD 0.033 million (INR 0.26 crore) for TANUVAS; USD 5.00 million (INR 40 crore); USD 7.141 million (INR 57.1 crore) and USD 0.671 million (INR 5.36 crore), respectively. Overall, financial benefits of PPR vaccine development and administration to control PPR in India outweighs the investment in manifolds.

Indexed as

Goat DiseasesPeste-des-Petits-RuminantsPeste-des-petits-ruminants virusViral VaccinesAnimalsGoatsIndiaIron-Dextran ComplexVaccine DevelopmentIron-Dextran ComplexViral Vaccinesgross technology revenueIndiaPeste des Petits Ruminantsresearch & development impactvaccine technology

Identifiers

PMID37258128
PMCPMC10372261
OpenAlexW4378741349

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.